Who has invested in Intellia Therapeutics?

No investors are named on the public record for Intellia Therapeutics yet.

Intellia Therapeutics Funding: $197M Raised, IPO (2016)

Intellia Therapeutics funding overview

Intellia Therapeutics is based in Cambridge, Massachusetts. Intellia Therapeutics has raised $197M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in January 2016. The round record for Intellia Therapeutics runs through 2016; nothing later has been disclosed.

Intellia Therapeutics at a glance

Total raised: $197M
Latest round: IPO
Latest round date: January 2016
Headquarters: Cambridge, Massachusetts

Frequently asked about Intellia Therapeutics funding

How much has Intellia Therapeutics raised?: Intellia Therapeutics has raised $197M in total disclosed funding across the rounds on record.
Who has invested in Intellia Therapeutics?: No investors are named on the public record for Intellia Therapeutics yet.
What was the latest Intellia Therapeutics funding round?: The most recent disclosed round is an IPO, announced in January 2016.
Where is Intellia Therapeutics based?: Intellia Therapeutics is based in Cambridge, Massachusetts.
When did Intellia Therapeutics last raise?: The last disclosed Intellia Therapeutics round closed in January 2016 at IPO.

Totals shown for Intellia Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.

Intellia Therapeutics Funding: $197M Raised, IPO (2016)

Intellia Therapeutics funding overview

Intellia Therapeutics at a glance

Frequently asked about Intellia Therapeutics funding

Companies related to Intellia Therapeutics (18)

Browse related funding lists (5)